Husain Yar Khan
Wayne State University
H-index: 19
North America-United States
Top articles of Husain Yar Khan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract CT080: A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic ductal adenocarcinoma | Cancer Research | Mandana Kamgar Husain Yar Khan Amro Aboukameel Sahar F Bannoura Brian Y Chung | 2024/4/5 |
Regulator of chromosome condensation 1 (RCC1) as a novel therapeutic target in pancreatic ductal adenocarcinoma | Cancer Research | Sahar F Bannoura Husain Y Khan Amro Aboukameel Md Hafiz Uddin Rund Nimri | 2024/3/22 |
Nuclear export inhibitor cooperates with PARP inhibitor to suppress the growth of metastatic castration resistant prostate cancer in vivo | Cancer Research | Md Hafiz Uddin Amro Aboukameel Husain Y Khan Sahar F Bannoura Frank Cackowski | 2024/3/22 |
Next generation nuclear export blocker KPT8602 synergizes with KRASG12D inhibitor MRTX1133 resulting in improved antitumor effects against pancreatic ductal … | Cancer Research | Husain Yar Khan Amro Aboukameel Md Hafiz Uddin Sahar F Bannoura Khaled Keffri | 2024/3/22 |
Abstract B077: KRASG12D inhibitor MRTX1133 synergizes with the next generation nuclear transport protein inhibitor eltanexor resulting in enhanced antitumor … | Cancer Research | Husain Y Khan Amro Aboukameel Md Hafiz Uddin Mohammad Najeeb Al-Hallak Eliza W Beal | 2024/1/16 |
Emerging talents in pharmacology of anti-cancer drugs 2022 | Frontiers in Pharmacology | Husain Yar Khan Khuloud Bajbouj Mai F Tolba | 2023/4/19 |
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis | bioRxiv | Sahar F Bannoura Amro Aboukameel Husain Yar Khan Md Hafiz Uddin Hyejeong Jang | 2023/12/18 |
Abstract LB299: Identification of key regulators for nuclear protein export inhibitor and chemotherapy combination in pancreatic cancer using spatial genomics approach | Cancer Research | Md Hafiz Uddin Sahar F Bannoura Husain Y Khan Amro Aboukameel Yiwei Li | 2023/4/14 |
Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model | Clinical and Translational Medicine | Md Hafiz Uddin Mohammad Najeeb Al‐Hallak Husain Yar Khan Amro Aboukameel Yiwei Li | 2023/12 |
A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma. | Mandana Kamgar Husain Yar Khan Amro Aboukameel Sahar Bannoura Brian Y Chung | 2023/2/1 | |
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers | Molecular Cancer Therapeutics | Husain Yar Khan Misako Nagasaka Amro Aboukameel Osama Alkhalili Md Hafiz Uddin | 2023/12/1 |
Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiation therapy | Advances in Radiation Oncology | Husain Yar Khan Mandana Kamgar Amro Aboukameel Sahar Bannoura Brian Y Chung | 2023/1/1 |
The clinical menin inhibitor ziftomenib and the nuclear export inhibitor selinexor synergistically inhibit the growth of MLL-r AML | Blood | Md Hafiz Uddin Amro Aboukameel Husain Khan Sahar Bannoura Abhinav Deol | 2023/11/2 |
P-76 Genomic and transcriptomic characterization of pancreatic neuroendocrine tumors reveals novel therapeutic candidates | Annals of Oncology | A Azmi Z Mahdi S Bannoura M Al-Hallak M Uddin | 2023/6/1 |
Association of PAK4 expression with overall survival in patients with non-small cell lung cancer (NSCLC). | Hirva Mamdani Sharon Wu Erin Morgan Husain Yar Khan Chadi Nabhan | 2022/6/1 | |
Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML | Blood | Md Hafiz Uddin Amro Aboukameel Husain Khan Sahar Bannoura Yiwei Li | 2022/11/15 |
Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C–mutant cancers | Cancer research communications | Husain Yar Khan Misako Nagasaka Yiwei Li Amro Aboukameel Md Hafiz Uddin | 2022/5/10 |
Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents | Cancer Research | Husain Yar Khan Sahar Bannoura Hirva Mamdani Amro Aboukameel Yousef Mzannar | 2022/6/15 |
Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model | bioRxiv | Md Hafiz Uddin Amro Aboukameel Yiwei Li Husain Yar Khan Rachel E Sexton | 2022/3/9 |
Nuclear protein export inhibitor selinexor chemotherapy combination for pancreatic cancer therapy | Cancer Research | Md Hafiz Uddin Sahar Bannoura Yiwei Li Husain Y Khan Amro Aboukameel | 2022/6/15 |
Co-Authors
